4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000036
CEO bought 191,000 shares at an average $0.01 ($2,294)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
30 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-30 | Purchase : show line 1 in the form | +10,000 | $0.01 | $115 | 23,976,097 | D |
| 2019-05-30 | Purchase : show line 2 in the form | +1,000 | $0.01 | $12 | 23,977,097 | D |
| 2019-05-30 | Purchase : show line 3 in the form | +5,000 | $0.01 | $59 | 23,982,097 | D |
| 2019-05-30 | Purchase : show line 4 in the form | +5,000 | $0.01 | $57 | 23,987,097 | D |
| 2019-05-30 | Purchase : show line 5 in the form | +5,000 | $0.01 | $57 | 23,992,097 | D |
| 2019-05-30 | Purchase : show line 6 in the form | +5,000 | $0.01 | $57 | 23,997,097 | D |
| 2019-05-30 | Purchase : show line 7 in the form | +2,000 | $0.01 | $22 | 23,999,097 | D |
| 2019-05-30 | Purchase : show line 8 in the form | +15,000 | $0.01 | $176 | 24,014,097 | D |
| Open-market purchases · 191,000 sh · avg $0.01 · $2,294 | ||||||
Loading xslF345X03/primary_doc.xml…